Ambeed.cn

首页 / 抑制剂/激动剂 / 内分泌学/激素 / Renin / Aliskiren

阿利克仑 /Aliskiren {[allProObj[0].p_purity_real_show]}

货号:A227203 同义名: SPP 100;CGP 60536

Aliskiren is a renin inhibitor with IC50 of 1.5 nM.

Aliskiren 化学结构 CAS号:173334-57-1
Aliskiren 化学结构
CAS号:173334-57-1
Aliskiren 3D分子结构
CAS号:173334-57-1
Aliskiren 化学结构 CAS号:173334-57-1
Aliskiren 3D分子结构 CAS号:173334-57-1
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Aliskiren 纯度/质量文件 产品仅供科研

货号:A227203 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell Host Microbe, 2024. Ambeed. [ A163338 ]
Cancer Res., 2024. Ambeed. [ A295334 ]
J. Pharm. Investig., 2024. Ambeed. [ A221527 , A691302 , A272538 , A187261 ]
J. Fungi, 2024, 10(11): 751. Ambeed. [ A796919 ]
JBC, 2024, 107935. Ambeed. [ A194396 ]
更多 >

Aliskiren 生物活性

靶点
  • Renin

    Renin, IC50:1.5 nM

描述 Aliskiren is an orally active renin inhibitor with IC50 value of 0.6nM, used as antihypertensive drugs that block the first step in the renin–angiotensin system, which can interrupt the negative feedback effects of angiotensin II on renin secretion. Administration of Aliskiren at dose of 150mg alone significantly inhibited plasma renin activity by 65% in patients with hypertension. Inhibition of renin by Aliskiren in combinations with hydrochlorothiazide, ramipril, or irbesartan increased renin–angiotensin system suppression, improved 24-hour blood pressure control.
作用机制 Aliskiren interacts with several binding pockets in distinct regions around the active site of renin.[2]

Aliskiren 动物研究

Dose Rat: 3 mg/kg - 30 mg/kg[4] (s.c.); 10 mg/kg[4] (i.v.); 1 mg/kg - 30 mg/kg[5] (p.o.), 200 mg/kg[6] (p.o.) Mice: 25 mg/kg[7] (osmotic minipump) Mice: 3 mg/kg - 25 mg/kg[8] (s.c.)
Administration s.c., i.v.
Pharmacokinetics
Animal Rats[9]
Dose 100 mg/kg (p.o.)
10 mg/kg (i.v.)
Administration p.o.
i.v.
F 2.4% (p.o.)
T1/2 23.1 h (i.v.)
Tmax 0.25 h (p.o.)
0.083 h (i.v.)
CL 1.2 L/h/kg (i.v.)
Cmax 0.27 μmol/L (p.o.)
29.20 μmol/L (i.v.)
Vss 7.8 L/kg (i.v.)
AUC 3.01 μmol·h/L (p.o.)
12.60 μmol·h/L (i.v.)

Aliskiren 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00865020 - Completed - -
NCT00841672 Moderate to Severe Hypertensio... 展开 >>n 收起 << Phase 3 Completed - Germany ... 展开 >> Investigative Site Berlin, Germany Philippines Investigative Site Manilla, Philippines Romania Investigative Site Bucharest, Romania Russian Federation Investigative Site Moscow, Russian Federation Singapore Investigative Site Singapore, Singapore Spain Investigative Site Madrid, Spain 收起 <<
NCT00841672 - Completed - -

Aliskiren 参考文献

[1]Wal P, Wal A, et al. Aliskiren: An orally active renin inhibitor. J Pharm Bioallied Sci. 2011 Apr;3(2):189-93.

[2]Jensen C, Herold P, et al. Aliskiren: the first renin inhibitor for clinical treatment. Nat Rev Drug Discov. 2008 May;7(5):399-410.

[3]O'Brien E, Barton J, et al. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker. Hypertension. 2007 Feb;49(2):276-84. Epub 2006 Dec 11.

[4]Feldman DL, Jin L, et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension. 2008 Jul;52(1):130-6.

[5]Wood JM, Schnell CR, et al. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats. J Hypertens. 2005 Feb;23(2):417-26.

[6]Un H, Bayir Y, et al. The Effects of RAAS Inhibition in Rate Limiting Step by Aliskiren on Testicular Torsion Injury in Rats. J Urol. 2015 Sep;194(3):828-33.

[7]Higashikuni Y, Takaoka M, et al. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice. Hypertens Res. 2012 Jan;35(1):62-9.

[8]Dong YF, Liu L, et al. Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes. Diabetologia. 2010 Jan;53(1):180-91.

[9]Aliskiren

Aliskiren 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.81mL

0.36mL

0.18mL

9.06mL

1.81mL

0.91mL

18.12mL

3.62mL

1.81mL

Aliskiren 技术信息

CAS号173334-57-1
分子式C30H53N3O6
分子量 551.758
别名 SPP 100;CGP 60536;Aliskiren, Enviage, Rasilez, Riprazo, SPP100, Sprimeo;CGP60536B
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 105 mg/mL(190.3 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

无水乙醇: 100 mg/mL(181.24 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。